SelfDiagnostics International Holding GmbH

SDIH delivers the earliest and most precise information on Lyme disease risk factors associated with a specific tick. We combine a handheld molecular test with an AI-driven engine using image, location, weather and season data. The information - available within 1 hour - enables much improved decisions by individuals and their doctors. As no human samples are analyzed, SDIH operates outside medical device regulation. Launch in US&Europe in autumn 2026.

SelfDiagnostics International Holding GmbH

Golfstr. 15
22605 Hamburg

https://selfdiagnostics.com/de/

Category

Medical Technology, Biotechnology / Pharma

Sub Category

medical disposables & consumer goods, diagnostics, information & communication technology